Hemodynamic MonitoringNCT03893513
Comparison of Transthoracic Electrical Bioimpedance and Pulse Contour Analysis in Renal Transplantation Patients
An observational study of Hemodynamic Monitoring, run by Dita Aditianingsih at 1 site in Indonesia.
Trial summary
Hemodynamics monitoring using non-invasive transthoracic electrical bioimpedance ICON are compatible with standard invasive monitoring using pulse contour analysis EV1000 Read more about this study
- Who is it for?
- Ages 18 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Hemodynamic Monitoring
- What is being tested?
- Transthoracic Electrical Bioimpedance and Pulse Contour Analysis
- Type of treatment
- Medical device
- How many people
- 50 participants
- Where
- 1 siteIndonesia
- Study dates
- 12 Mar 2019to 12 May 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Patients planned to undergo elective kidney transplantation surgery as recipient
Who may be able to join
- BMI 18.5 - 35 kg/m^2
Who cannot join
- Heart function abnormalities (arrhythmia, AV block, using pacemaker, severe aorta stenosis)
- Morbid obesity
- Bradycardia (< 50 bpm)
- Tachycardia (> 110 bpm)
- refuse to participate
Trial locations and contacts
1 site in 1 country.
Indonesia1 site
Rumah Sakit Cipto Mangunkusumo
Jakarta Pusat, DKI Jakarta, 10430
About this study
Official title: Comparison of Transthoracic Electrical Bioimpedance and Pulse Contour Analysis in Renal Transplantation Patients: Analysis of Intraoperative Cardiac Output, Systemic Vascular Resistant and Stroke Volume Variation
Hemodynamics monitoring using non-invasive transthoracic electrical bioimpedance ICON are compatible with standard invasive monitoring using pulse contour analysis EV1000
- Conditions
- Hemodynamic Monitoring
- Being tested
- Transthoracic Electrical Bioimpedance, Pulse Contour Analysis
- Keywords
- Bio-impedance, Haemodynamic monitoring, Pulse contour analysis, kidney transplantation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Transthoracic Electrical BioimpedanceDevice
Also called ICON
Non-invasive hemodynamic monitor
Pulse Contour AnalysisDevice
Also called EV1000
Invasive hemodynamic monitor
What is being measured
The primary outcome is the main question the study is designed to answer.
Hemodynamic correlation
Correlation between hemodynamic measured between devices: cardiac index, stroke volume index, systemic vascular resistance index, stroke volume index
Measured: Intraoperative
Secondary outcomes (4)
Changes in hemodynamic profiles: Cardiac Index
The trends of perioperative hemodynamic profiles during and after surgery: cardiac index in L/minutes/m^2
Measured: Intraoperative
Changes in hemodynamic profiles: Stroke Volume Index
The trends of perioperative haemodynamic profiles during and after surgery: stroke volume index in mL/beat/m^2
Measured: Intraoperative
Changes in hemodynamic profiles: Systemic Vascular Resistance Index
The trends of perioperative haemodynamic profiles during and after surgery: systemic vascular resistance index in dynes-second-m^2/cm^5
Measured: Intraoperative
Changes in hemodynamic profiles: Stroke Volume Variation
The trends of perioperative haemodynamic profiles during and after surgery: stroke volume variation in %
Measured: Intraoperative
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Mar 2019
- Study start12 Mar 2019
- Primary completion12 Apr 2019
- Study completion12 May 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (27)Papers the sponsor has linked to this study.
- Other trials for Hemodynamic MonitoringStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dita Aditianingsih
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Dita Aditianingsih, Universitas Indonesia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03893513
- Sponsor's protocol ID
- IndonesiaUAnes032
- Status last verified
- Jun 2019
- First submitted
- 26 Mar 2019
- Last updated
- 18 Jun 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
Publications
Vincent JL, Pelosi P, Pearse R, Payen D, Perel A, Hoeft A, Romagnoli S, Ranieri VM, Ichai C, Forget P, Della Rocca G, Rhodes A. Perioperative cardiovascular monitoring of high-risk patients: a consensus of 12. Crit Care. 2015 May 8;19(1):224. doi: 10.1186/s13054-015-0932-7.
PubMed 25953531Joosten A, Huynh T, Suehiro K, Canales C, Cannesson M, Rinehart J. Goal-Directed fluid therapy with closed-loop assistance during moderate risk surgery using noninvasive cardiac output monitoring: A pilot study. Br J Anaesth. 2015 Jun;114(6):886-92. doi: 10.1093/bja/aev002. Epub 2015 Feb 17.
PubMed 25690834Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G, Grocott MP, Ahern A, Griggs K, Scott R, Hinds C, Rowan K; OPTIMISE Study Group. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. 2014 Jun 4;311(21):2181-90. doi: 10.1001/jama.2014.5305.
PubMed 24842135Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg. 2011 Jun;112(6):1392-402. doi: 10.1213/ANE.0b013e3181eeaae5. Epub 2010 Oct 21.
PubMed 20966436Sinclair S, James S, Singer M. Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: randomised controlled trial. BMJ. 1997 Oct 11;315(7113):909-12. doi: 10.1136/bmj.315.7113.909.
PubMed 9361539Edison E, Pearse R. Goal directed therapy in the perioperative setting: What is the evidence? In: Paradise Lost and the Cosmological Revolution. 2014.
Aya HD, Cecconi M, Rhodes A. Perioperative Haemodynamic Optimisation. Turk J Anaesthesiol Reanim. 2014 Apr;42(2):56-65. doi: 10.5152/TJAR.2014.2220141. Epub 2014 Apr 1.
PubMed 27366392Saugel B, Cecconi M, Wagner JY, Reuter DA. Noninvasive continuous cardiac output monitoring in perioperative and intensive care medicine. Br J Anaesth. 2015 Apr;114(4):562-75. doi: 10.1093/bja/aeu447. Epub 2015 Jan 16.
PubMed 25596280Alhashemi JA, Cecconi M, Hofer CK. Cardiac output monitoring: an integrative perspective. Crit Care. 2011;15(2):214. doi: 10.1186/cc9996. Epub 2011 Mar 22. No abstract available.
PubMed 21457508Allaria B, Poli DM CD. Perioperative hemodynamic monitoring: invasive vs. non-invasive. In: Anesthesia, Pain, Intensive Care and Emergency Medicine - APICE. Italy: Springer-Verlag; 2013. p. 291-9.
Boyd O, Jackson N. How is risk defined in high-risk surgical patient management? Crit Care. 2005 Aug;9(4):390-6. doi: 10.1186/cc3057. Epub 2005 Feb 9.
PubMed 16137389Goldfarb D, Poggio E. Etiology, pathogenesis, and management of renal failure. In: Wein A, Kavoussi L, Novick A, Partin A, Peters C, editors. Campbell-Walsh Urology. 10th ed. Philadelphia: Elsevier Saunders; 2012. p. 1226-53.
Angelotti T, Lemmens H. Liver/Kidney/Pancreas transplantation. In: Jaffe R, Schmiesing C, Golianu B, editors. Anesthesiologist's Manual of Surgical Procedures. 5th editio. Philadelphia: Wolters Kluwer Health; 2014. p. 1097-100.
Darovic G. Hemodynamic monitoring: invasive and noninvasive clinical applications. 3rd ed. Darovic G, editor. Philadelphia: W.B. Saunders; 2002. 191-260 p.
Bendjelid K, Marx G, Kiefer N, Simon TP, Geisen M, Hoeft A, Siegenthaler N, Hofer CK. Performance of a new pulse contour method for continuous cardiac output monitoring: validation in critically ill patients. Br J Anaesth. 2013 Oct;111(4):573-9. doi: 10.1093/bja/aet116. Epub 2013 Apr 26.
PubMed 23625132
Study at a glance
From the registry record, last updated by the sponsor on 18 Jun 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Transthoracic Electrical Bioimpedance and Pulse Contour Analysis in Renal Transplantation Patients: Analysis of Intraoperative Cardiac Output, Systemic Vascular Resistant and Stroke Volume Variation
- ClinicalTrials.gov ID
- NCT03893513
- Acronym / sponsor ID
- IndonesiaUAnes032
- Conditions
- Hemodynamic Monitoring
- Keywords
- Bio-impedance, Haemodynamic monitoring, Pulse contour analysis, kidney transplantation
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Dita AditianingsihUniversity, hospital or other
- Study start
- 12 Mar 2019 (actual)
- Primary completion
- 12 Apr 2019 (actual)
- Study completion
- 12 May 2019 (actual)
- First posted
- 28 Mar 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Hemodynamics monitoring using non-invasive transthoracic electrical bioimpedance ICON are compatible with standard invasive monitoring using pulse contour analysis EV1000
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Patients planned to undergo elective kidney transplantation surgery as recipient
Key inclusion criteria (1 listed)
- BMI 18.5 - 35 kg/m^2
Key exclusion criteria (5 listed)
- Heart function abnormalities (arrhythmia, AV block, using pacemaker, severe aorta stenosis)
- Morbid obesity
- Bradycardia (< 50 bpm)
- Tachycardia (> 110 bpm)
- refuse to participate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Transthoracic Electrical BioimpedanceAlso: ICONNon-invasive hemodynamic monitor | Device | – |
| Pulse Contour AnalysisAlso: EV1000Invasive hemodynamic monitor | Device | – |
Primary outcome
Hemodynamic correlation
Time frame: Intraoperative
Correlation between hemodynamic measured between devices: cardiac index, stroke volume index, systemic vascular resistance index, stroke volume index
4 secondary outcomes
Changes in hemodynamic profiles: Cardiac Index
Time frame: Intraoperative
Changes in hemodynamic profiles: Stroke Volume Index
Time frame: Intraoperative
Changes in hemodynamic profiles: Systemic Vascular Resistance Index
Time frame: Intraoperative
Changes in hemodynamic profiles: Stroke Volume Variation
Time frame: Intraoperative
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jun 2019.
- Background: PubMed 25953531Vincent JL, Pelosi P, Pearse R, Payen D, Perel A, Hoeft A, Romagnoli S, Ranieri VM, Ichai C, Forget P, Della Rocca G, Rhodes A. Perioperative cardiovascular monitoring of high-risk patients: a consensus of 12. Crit Care. 2015 May 8;19(1):224. doi: 10.1186/s13054-015-0932-7.
- Background: PubMed 25690834Joosten A, Huynh T, Suehiro K, Canales C, Cannesson M, Rinehart J. Goal-Directed fluid therapy with closed-loop assistance during moderate risk surgery using noninvasive cardiac output monitoring: A pilot study. Br J Anaesth. 2015 Jun;114(6):886-92. doi: 10.1093/bja/aev002. Epub 2015 Feb 17.
- Background: PubMed 24842135Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G, Grocott MP, Ahern A, Griggs K, Scott R, Hinds C, Rowan K; OPTIMISE Study Group. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. 2014 Jun 4;311(21):2181-90. doi: 10.1001/jama.2014.5305.
- Background: PubMed 20966436Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg. 2011 Jun;112(6):1392-402. doi: 10.1213/ANE.0b013e3181eeaae5. Epub 2010 Oct 21.
- Background: PubMed 9361539Sinclair S, James S, Singer M. Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: randomised controlled trial. BMJ. 1997 Oct 11;315(7113):909-12. doi: 10.1136/bmj.315.7113.909.
- BackgroundEdison E, Pearse R. Goal directed therapy in the perioperative setting: What is the evidence? In: Paradise Lost and the Cosmological Revolution. 2014.
- Background: PubMed 27366392Aya HD, Cecconi M, Rhodes A. Perioperative Haemodynamic Optimisation. Turk J Anaesthesiol Reanim. 2014 Apr;42(2):56-65. doi: 10.5152/TJAR.2014.2220141. Epub 2014 Apr 1.
- Background: PubMed 25596280Saugel B, Cecconi M, Wagner JY, Reuter DA. Noninvasive continuous cardiac output monitoring in perioperative and intensive care medicine. Br J Anaesth. 2015 Apr;114(4):562-75. doi: 10.1093/bja/aeu447. Epub 2015 Jan 16.
- Background: PubMed 21457508Alhashemi JA, Cecconi M, Hofer CK. Cardiac output monitoring: an integrative perspective. Crit Care. 2011;15(2):214. doi: 10.1186/cc9996. Epub 2011 Mar 22. No abstract available.
- BackgroundAllaria B, Poli DM CD. Perioperative hemodynamic monitoring: invasive vs. non-invasive. In: Anesthesia, Pain, Intensive Care and Emergency Medicine - APICE. Italy: Springer-Verlag; 2013. p. 291-9.
- Background: PubMed 16137389Boyd O, Jackson N. How is risk defined in high-risk surgical patient management? Crit Care. 2005 Aug;9(4):390-6. doi: 10.1186/cc3057. Epub 2005 Feb 9.
- BackgroundGoldfarb D, Poggio E. Etiology, pathogenesis, and management of renal failure. In: Wein A, Kavoussi L, Novick A, Partin A, Peters C, editors. Campbell-Walsh Urology. 10th ed. Philadelphia: Elsevier Saunders; 2012. p. 1226-53.
Related trials for Hemodynamic Monitoring
RecruitingObservational study
Comparison of Hemodynamic Responses During Anesthesia Induction Using Eleveld and Schnider
Spinal (Fusion) Surgery, Total Intravenous Anesthesia
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Heart Failure, Heart Diseases
Not yet recruitingObservational study
Ultrasound-Calibrated Pulse Contour Cardiac Output Monitoring: Value and Accuracy in Hemodynamic Care
Sepsis, Circulatory Instability
Not yet recruiting
UltraTrac for Cardiac Output Monitoring in Congenital Heart Disease
Congenital Heart Disease, Cardiac Output
Not yet recruiting
ASSISTED FLUID MANAGEMENT SYSTEM IN KIDENY TRANSPLANTATION
Kidney Transplant
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hemodynamic Monitoring, run by Dita Aditianingsih at 1 site in Indonesia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Jun 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hemodynamic correlation (time frame: Intraoperative). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03893513, which also lists 27 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2019.